PMV Pharmaceuticals Ownership | Who Owns PMV Pharmaceuticals?
PMV Pharmaceuticals Ownership Summary
PMV Pharmaceuticals is owned by 23.53% institutional investors, 2.30% insiders, and 74.17% retail investors. Orbimed advisors is the largest institutional shareholder, holding 12.56% of PMVP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.95% of its assets in PMV Pharmaceuticals shares.
PMVP Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | PMV Pharmaceuticals | 23.53% | 2.30% | 74.17% |
Sector | Healthcare Stocks | 57.43% | 9.41% | 33.16% |
Industry | Biotech Stocks | 69.02% | 8.92% | 22.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Orbimed advisors | 6.48M | 12.56% | $9.78M |
Sio capital management | 3.57M | 6.93% | $5.39M |
Arrowmark colorado | 3.51M | 6.80% | $5.30M |
Bml capital management | 3.47M | 6.72% | $5.23M |
Euclidean capital | 2.63M | 5.09% | $3.97M |
Alkeon capital management | 2.34M | 4.54% | $3.54M |
Vanguard group | 2.14M | 4.16% | $3.24M |
Pfm health sciences, lp | 2.08M | 4.03% | $3.14M |
Acadian asset management | 2.08M | 4.03% | $3.14M |
Blackrock | 1.16M | 2.26% | $1.88M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Bml capital management | 3.47M | 3.25% | $5.23M |
Sio capital management | 3.57M | 1.52% | $5.39M |
Aldebaran capital | 502.19K | 0.72% | $758.31K |
Stonepine capital management | 535.80K | 0.65% | $809.07K |
Euclidean capital | 2.63M | 0.54% | $3.97M |
Orbimed advisors | 6.48M | 0.20% | $9.78M |
Pfm health sciences, lp | 2.08M | 0.19% | $3.14M |
Arrowmark colorado | 3.51M | 0.07% | $5.30M |
Velan capital investment management lp | 35.00K | 0.05% | $52.85K |
Shay capital | 156.45K | 0.04% | $236.24K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bml capital management | 3.47M | 3.25% | 1.78M |
Stonepine capital management | 535.80K | 0.65% | 535.80K |
Sio capital management | 3.57M | 1.52% | 357.93K |
Prelude capital management | 134.70K | 0.02% | 103.60K |
Ubs group | 275.46K | 0.00% | 96.60K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 1.16M | - | -1.95M |
Bank of america corp /de/ | 340.39K | - | -1.03M |
State street | 145.08K | - | -640.91K |
Ecor1 capital | - | - | -566.88K |
Personal cfo solutions | - | - | -550.34K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Stonepine capital management | 535.80K | 0.65% | 535.80K | $809.07K |
Velan capital investment management lp | 35.00K | 0.05% | 35.00K | $52.85K |
Russell investments group | 4.71K | - | 4.71K | $7.63K |
Macquarie group | 2.08K | - | 2.08K | $3.37K |
Bnp paribas arbitrage, snc | 763.00 | - | 763.00 | $1.15K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -8.00 |
Avion wealth | -299.00 |
Capital advisors | -322.00 |
New york state common retirement fund | -341.00 |
Private wealth management group | -676.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 23 | -69.33% | 12,134,994 | -68.90% | 23 | 0.41% | 7 | -75.00% | 8 | -72.41% |
Sep 30, 2024 | 75 | -19.35% | 39,023,924 | -3.62% | 75 | 1.22% | 29 | -35.56% | 29 | -6.45% |
Jun 30, 2024 | 93 | -7.00% | 40,490,486 | -5.27% | 78 | 1.14% | 45 | -10.00% | 31 | 19.23% |
Mar 31, 2024 | 100 | -2.91% | 42,741,191 | -8.02% | 83 | 0.93% | 50 | -13.79% | 26 | -13.33% |
Dec 31, 2023 | 103 | -8.04% | 46,466,060 | -14.33% | 94 | 0.68% | 58 | 18.37% | 30 | -11.76% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.52M | 2.95% | - |
ArrowMark Small Cap Gro | 1.26M | 2.43% | - |
Meridian Small Cap Growth Legacy | 1.26M | 2.43% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 540.35K | 1.04% | - |
SQUAD Aguja Opportunities I | 450.00K | 0.87% | - |
BlackRock Advantage Small Cap Core Instl | 280.44K | 0.54% | - |
Goldman Sachs Small Cp Val Insghts Instl | 249.01K | 0.48% | - |
Fidelity Extended Market Index | 220.95K | 0.43% | -10.14K |
Vanguard Health Care ETF | 140.02K | 0.27% | 2.32K |
Bridgeway Ultra-Small Company Market | 124.40K | 0.24% | -15.50K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 11, 2024 | Jalota Deepika | Chief Development Officer | Sell | $10.85K |
Sep 11, 2024 | Carulli Michael | Chief Financial Officer | Sell | $4.35K |
Nov 22, 2023 | ORBIMED ADVISORS LLC | - | Sell | $195.76K |
Sep 15, 2023 | Jalota Deepika | Chief Development Officer | Sell | $27.17K |
Sep 15, 2023 | Alland Leila | Chief Medical Officer | Sell | $41.65K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | - | - |
2024 Q3 | - | 2 |
2024 Q2 | - | - |
2024 Q1 | - | - |
PMVP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools